Madelyn Luttgen

1.9k total citations
28 papers, 1.3k citations indexed

About

Madelyn Luttgen is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Madelyn Luttgen has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Madelyn Luttgen's work include Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (15 papers) and Prostate Cancer Treatment and Research (5 papers). Madelyn Luttgen is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (15 papers) and Prostate Cancer Treatment and Research (5 papers). Madelyn Luttgen collaborates with scholars based in United States and Canada. Madelyn Luttgen's co-authors include Peter Kühn, Kelly Bethel, Anand Kolatkar, John Southon, Shuhui Zheng, Julia Liu, Xiaomei Xu, Susan Trumbore, Jorge J. Nieva and Dena Marrinucci and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Madelyn Luttgen

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Madelyn Luttgen

Since Specialization

Citations

This map shows the geographic impact of Madelyn Luttgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madelyn Luttgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madelyn Luttgen more than expected).

Fields of papers citing papers by Madelyn Luttgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madelyn Luttgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madelyn Luttgen. The network helps show where Madelyn Luttgen may publish in the future.

Co-authorship network of co-authors of Madelyn Luttgen

This figure shows the co-authorship network connecting the top 25 collaborators of Madelyn Luttgen. A scholar is included among the top collaborators of Madelyn Luttgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madelyn Luttgen. Madelyn Luttgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients	Physical Biology	Carmen Ruiz Velasco, Madelyn Luttgen et al.	39
2	A physical sciences network characterization of circulating tumor cell aggregate transport	American Journal of Physiology-Cell Physiology	Michael R. King, Kevin G. Phillips et al.	54
3	Circulating Tumor Microemboli Diagnostics for Patients with Non–Small-Cell Lung Cancer	Journal of Thoracic Oncology	Anders Carlsson, Viswam S. Nair et al.	59
4	Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells	PLoS ONE	Angel E. Dago, Asya Stepansky et al.	116
5	Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction	Physical Biology	Kelly Bethel, Madelyn Luttgen et al.	27
6	Fourier-ring descriptor to characterize rare circulating cells from images generated using immunofluorescence microscopy	Computerized Medical Imaging and Graphics	Tegan Emerson, Michael Kirby et al.	4
7	Abstract 4006: MicroRNA footprints of circulating tumor cells in patients with non-small cell lung cancer	Cancer Research	Viswam S. Nair, María D. Giraldez et al.	8
8	Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates	Annals of Oncology	Robin Kate Kelley, Halla Nimeiri et al.	50
9	An Observational Study of Circulating Tumor Cells and 18F-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer	PLoS ONE	Viswam S. Nair, Khun Visith Keu et al.	34
10	Dynamic changes in circulating tumor cell levels as a prognostic marker in stage IV non-small cell lung cancer.	Journal of Clinical Oncology	Anders Carlsson, Lyudmila Bazhenova et al.	1
11	Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line	Physical Biology	Daniel C. Lazar, Edward H. Cho et al.	53
12	Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors	Physical Biology	Edward H. Cho, Marco Wendel et al.	169
13	High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis	Physical Biology	Jorge J. Nieva, Marco Wendel et al.	88
14	Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient	SHILAP Revista de lepidopterología	Kevin G. Phillips, Anand Kolatkar et al.	36
15	Performance of the high-definition circulating tumor cells (HD-CTC) assay in patients with non-small cell lung cancer (NSCLC).	Journal of Clinical Oncology	Lyudmila Bazhenova, Jorge J. Nieva et al.	4
16	Optical Quantification of Cellular Mass, Volume, and Density of Circulating Tumor Cells Identified in an Ovarian Cancer Patient	SHILAP Revista de lepidopterología	Kevin Phillips, Carmen Ruiz Velasco et al.	70
17	Non-enrichment-based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate-resistant prostate cancer.	Journal of Clinical Oncology	Mitchell E. Gross, Daniel C. Lazar et al.	1
18	Circulating tumor cells (CTC) in mesothelioma and its cytomorphological and immunohistochemical correlation with the primary tumor specimens.	Journal of Clinical Oncology	Lyudmila Bazhenova, Saskia Boisot et al.	4
19	Circulating Tumor Cells From Well-Differentiated Lung Adenocarcinoma Retain Cytomorphologic Features of Primary Tumor Type	Archives of Pathology & Laboratory Medicine	Dena Marrinucci, Kelly Bethel et al.	60
20	Modifying a sealed tube zinc reduction method for preparation of AMS graphite targets: Reducing background and attaining high precision	Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms	Xiaomei Xu, Susan Trumbore et al.	374

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact